304
Participants
Start Date
September 27, 2021
Primary Completion Date
August 14, 2023
Study Completion Date
August 14, 2023
Ad26.COV2.S
Ad26.COV2.S will be administered as intramuscular (IM) injection.
Setshaba Research Centre, Soshanguve
Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, Soweto
Shandukani Research Centre, Johannesburg
University of Witwatersrand - Helen Joseph Hospital - Themba Lethu Hiv Research Centre, Westdene Johannesburg Gauteng
Hospital del Niño Jesús, San Miguel de Tucumán
Hospital de Ninos de Cordoba, Córdoba
Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey
BAPS Pramukhswami Hospital, Surat
JSS Hospital, Mysore
Sri ramchandra Medical College & Research Institute, Chennai
CIPREC, Buenos Aires
Universidade Federal De Minas Gerais - Hospital das Clínicas, Belo Horizonte
Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte
Hospital Das Clinicas Da Faculdade De Medicina De RPUSP HCRP, Ribeirão Preto
CPQuali Pesquisa Clinica LTDA ME, São Paulo
Supe Heart And Diabetes Hospital and Research Center, Nashik
CAIMED Investigacion en salud S.A de C.V., Mexico City
Ndlovu Elandsdoorn Site, Dennilton
Janssen Vaccines & Prevention B.V.
INDUSTRY